Syros Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SYRS and buy or sell other stocks, ETFs, and their options commission-free!

About SYRS

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. 

CEO
Nancy A. Simonian
CEONancy A. Simonian
Employees
124
Employees124
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2011
Founded2011
Employees
124
Employees124

SYRS Key Statistics

Market cap
630.05K
Market cap630.05K
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
5.31M
Average volume5.31M
High today
$0.028
High today$0.028
Low today
$0.01
Low today$0.01
Open price
$0.028
Open price$0.028
Volume
3.19K
Volume3.19K
52 Week high
$5.22
52 Week high$5.22
52 Week low
$0.01
52 Week low$0.01

People also own

Based on the portfolios of people who own SYRS. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
NIO
Cenntro Inc.
Tilray Brands
Ocugen, Inc
Plug Power
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.